• Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    Metabolomic analysis of pegylated arginine deiminase treatment in patients with malignant pleural mesothelioma 
    •   QMRO Home
    • Barts Cancer Institute
    • Centre for Haemato-Oncology
    • Metabolomic analysis of pegylated arginine deiminase treatment in patients with malignant pleural mesothelioma
    •   QMRO Home
    • Barts Cancer Institute
    • Centre for Haemato-Oncology
    • Metabolomic analysis of pegylated arginine deiminase treatment in patients with malignant pleural mesothelioma
    ‌
    ‌

    Browse

    All of QMROCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects
    ‌
    ‌

    Administrators only

    Login
    ‌
    ‌

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Metabolomic analysis of pegylated arginine deiminase treatment in patients with malignant pleural mesothelioma

    View/Open
    Accepted version (14.77Kb)
    Volume
    32
    DOI
    10.1200/jco.2014.32.15_suppl.7587
    Issue
    15
    ISSN
    0732-183X
    Metadata
    Show full item record
    Authors
    Ghazaly, EA; Luong, P; Chmielewska-Kassassir, M; Wozniak, L; Bomalaski, JS; Gribben, JG; Szlosarek, PW
    URI
    http://meetinglibrary.asco.org/content/134875-144
    http://qmro.qmul.ac.uk/xmlui/handle/123456789/11295
    Collections
    • Centre for Haemato-Oncology [157]
    Copyright statements
    American Society of Clinical Oncology
    Twitter iconFollow QMUL on Twitter
    Twitter iconFollow QM Research
    Online on twitter
    Facebook iconLike us on Facebook
    • Site Map
    • Privacy and cookies
    • Disclaimer
    • Accessibility
    • Contacts
    • Intranet
    • Current students

    Modern Slavery Statement

    Queen Mary University of London
    Mile End Road
    London E1 4NS
    Tel: +44 (0)20 7882 5555

    © Queen Mary University of London.